Painful Na-channelopathies: An expanding universe

Trends in Molecular Medicine

Volumn 19, Issue 7, 2013, Pages 406-409

  Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

channelopathy; pain; sodium channels

Indexed keywords

CARBAMAZEPINE; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; VOLTAGE GATED SODIUM CHANNEL;

CHANNELOPATHY INSENSITIVITY TO PAIN; CLINICAL FEATURE; DRUG RESPONSE; ERYTHROMELALGIA; GAIN OF FUNCTION MUTATION; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENOTYPE; HUMAN; LOSS OF FUNCTION MUTATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PAROXYSMAL EXTREME PAIN DISORDER; PERIPHERAL NEUROPATHY; PHARMACOGENOMICS; PHENOTYPE; RARE DISEASE; REVIEW; SCN10A GENE; SCN9A GENE; SMALL FIBER NEUROPATHY; SODIUM CHANNELOPATHY;

ANIMALS; CHANNELOPATHIES; ERYTHROMELALGIA; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; PAIN; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; PHARMACOGENETICS; RECTUM; SODIUM CHANNELS;

EID: 84879782727     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.04.003     Document Type: Review

References (32)

1. Dib-Hajj S.D., et al. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 2010, 33:325-347.
2. Eijkelkamp N., et al. Neurological perspectives on voltage-gated sodium channels. Brain 2012, 135:2585-2612.
3. Drenth J.P., et al. The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am. J. Hum. Genet. 2001, 68:1277-1282.
4. Yang Y., et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 2004, 41:171-174.
5. Cummins T.R., et al. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 2004, 24:8232-8236.
6. Dib-Hajj S.D., et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005, 128:1847-1854.
7. Dib-Hajj S.D., et al. The Na(V)1.7 sodium channel: from molecule to man. Nat. Rev. Neurosci. 2012, 14:49-62.
8. Drenth J.P., Waxman S.G. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J. Clin. Invest. 2007, 117:3603-3609.
9. Fertleman C.R., et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52:767-774.
10. Estacion M., et al. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J. Neurosci. 2008, 28:11079-11088.
11. Ahmad S., et al. A stop codon mutation in SCN9A causes lack of pain sensation. Hum. Mol. Genet. 2007, 16:2114-2121.
12. Cox J.J., et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444:894-898.
13. Goldberg Y.P., et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet. 2007, 71:311-319.
14. Rush A.M., et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8245-8250.
15. Toledo-Aral J.J., et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1527-1532.
16. Weiss J., et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 2011, 472:186-190.
17. Ahn H.S., et al. Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons. Mol. Pain 2011, 7:32.
18. Hoeijmakers J.G., et al. Small-fibre neuropathies - advances in diagnosis, pathophysiology and management. Nat. Rev. Neurol. 2012, 8:369-379.
19. Faber C.G., et al. Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy. Ann. Neurol. 2012, 71:26-39.
20. Hoeijmakers J.G., et al. Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation. Brain 2012, 135:345-358.
21. Faber C.G., et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:19444-19449.
22. Cheng X., et al. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade. Mol. Pain 2008, 4:1.
23. Han C., et al. Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. Brain 2009, 132:1711-1722.
24. Han C., et al. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain 2012, 135:2613-2628.
25. Estacion M., et al. Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol. Pain 2011, 7:92.
26. Estacion M., et al. A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann. Neurol. 2009, 66:862-866.
27. Reimann F., et al. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5148-5153.
28. Black J.A., et al. Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann. Neurol. 2008, 64:644-653.
29. Payandeh J., et al. The crystal structure of a voltage-gated sodium channel. Nature 2011, 475:353-358.
30. Yang Y., et al. Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(v)1.7 mutant channel. Nat. Commun. 2012, 3:1186.
31. Fischer T.Z., et al. A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann. Neurol. 2009, 65:733-741.
32. Dib-Hajj S.D., Waxman S.G. Isoform-specific and pan-channel partners regulate trafficking and plasma membrane stability; and alter sodium channel gating properties. Neurosci. Lett. 2010, 486:84-91.